Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)

Market Cap	75.53B -19.7%
Revenue (ttm)	15.25B +16.1%
Net Income	2.50B +5.7%
EPS	7.14 +5.7%
Shares Out	350.00M
PE Ratio	30.23
Forward PE	25.53
Dividend	4.83 (2.24%)
Ex-Dividend Date	Nov 1, 2026

Volume	366,809
Open	214.50
Previous Close	213.40
Day's Range	214.50 - 220.00
52-Week Range	207.30 - 269.20
Beta	0.04
Analysts	Buy
Price Target	265.65 (+23.1%)
Earnings Date	Oct 27, 2026

About TADAWUL:4013

Dr. Sulaiman Al Habib Medical Services Group Company, together with its subsidiaries, provides private health and support services in the Kingdom of Saudi Arabia. It operates through three segments: Hospitals/Healthcare Facilities, Pharmacies, and Other Solutions Sector. The company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, and pharmaceutical facilities. It also provides home medical care; specialized medical laboratories; information technology and systems; facility maintenanc...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1993
• Employees: 10,475
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4013

Financial Performance

In 2025, TADAWUL:4013's revenue was 13.71 billion, an increase of 22.38% compared to the previous year's 11.20 billion. Earnings were 2.40 billion, an increase of 3.72%.

Analyst Summary

According to 14 analysts, the average rating for 4013 stock is "Buy." The 12-month stock price target is SAR 265.65, which is an increase of 23.10% from the latest price.

Price Target

SAR 265.65

(23.10% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 6, 2026

Data Sources Report a data error